Cármen Jerónimo

16.1k total citations
324 papers, 11.4k citations indexed

About

Cármen Jerónimo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Cármen Jerónimo has authored 324 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 237 papers in Molecular Biology, 105 papers in Pulmonary and Respiratory Medicine and 105 papers in Cancer Research. Recurrent topics in Cármen Jerónimo's work include Epigenetics and DNA Methylation (139 papers), Prostate Cancer Treatment and Research (57 papers) and Cancer-related gene regulation (42 papers). Cármen Jerónimo is often cited by papers focused on Epigenetics and DNA Methylation (139 papers), Prostate Cancer Treatment and Research (57 papers) and Cancer-related gene regulation (42 papers). Cármen Jerónimo collaborates with scholars based in Portugal, United States and United Kingdom. Cármen Jerónimo's co-authors include Rui Henrique, Jorge Oliveira, David Sidransky, Manuel R. Teixeira, João Lobo, Franclim R. Ribeiro, Vera L. Costa, Carlos Lopes, Márcia Carvalho and Mohammad Obaidul Hoque and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Cármen Jerónimo

308 papers receiving 11.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cármen Jerónimo Portugal	56	8.3k	3.6k	2.8k	1.6k	1.4k	324	11.4k
Rui Henrique Portugal	56	7.2k 0.9×	3.5k 1.0×	3.1k 1.1×	1.9k 1.2×	1.6k 1.1×	408	11.4k
Jian Gu United States	55	6.6k 0.8×	3.0k 0.8×	1.5k 0.5×	1.4k 0.9×	2.0k 1.4×	333	10.5k
Bin Li China	50	6.6k 0.8×	3.2k 0.9×	1.6k 0.6×	755 0.5×	2.1k 1.5×	394	10.3k
Mohammad Obaidul Hoque United States	52	5.9k 0.7×	2.0k 0.5×	1.7k 0.6×	1.3k 0.8×	1.8k 1.2×	133	8.3k
Srinivasan Yegnasubramanian United States	52	6.3k 0.8×	2.7k 0.7×	3.8k 1.4×	709 0.4×	1.6k 1.1×	166	9.9k
Min Yan China	55	6.5k 0.8×	4.0k 1.1×	2.7k 1.0×	1.3k 0.8×	3.2k 2.2×	392	11.7k
Edward Gabrielson United States	60	9.9k 1.2×	3.1k 0.8×	1.9k 0.7×	933 0.6×	3.4k 2.4×	135	13.7k
Xin Chen China	58	6.6k 0.8×	3.2k 0.9×	1.1k 0.4×	1.7k 1.0×	2.2k 1.5×	382	11.7k
Bingya Liu China	58	6.9k 0.8×	4.6k 1.3×	1.4k 0.5×	943 0.6×	2.5k 1.7×	295	10.5k
Colleen C. Nelson Australia	56	5.1k 0.6×	2.5k 0.7×	3.1k 1.1×	502 0.3×	2.2k 1.5×	197	9.5k

Countries citing papers authored by Cármen Jerónimo

Since Specialization

Citations

This map shows the geographic impact of Cármen Jerónimo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cármen Jerónimo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cármen Jerónimo more than expected).

Fields of papers citing papers by Cármen Jerónimo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cármen Jerónimo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cármen Jerónimo. The network helps show where Cármen Jerónimo may publish in the future.

Co-authorship network of co-authors of Cármen Jerónimo

This figure shows the co-authorship network connecting the top 25 collaborators of Cármen Jerónimo. A scholar is included among the top collaborators of Cármen Jerónimo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cármen Jerónimo. Cármen Jerónimo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Milanez‐Almeida, Pedro, Inês Alves, Ângela Fernandes, et al.. (2025). “Mannose glycans as key players in trained immunity: A novel anti-tumoral catalyst”. Biochimica et Biophysica Acta (BBA) - General Subjects. 1869(5). 130779–130779. 1 indexed citations

Ferreira, Vı́tor F., António Ferreira, Rui Henrique, et al.. (2025). Non-invasive bladder cancer detection: Identification of a urinary volatile biomarker panel using GC-MS metabolomics and machine learning. Talanta. 297(Pt B). 128749–128749.

Carvalho, Márcia, Cármen Jerónimo, Rui Henrique, et al.. (2025). Metabolic signature of renal cell carcinoma tumours and its correlation with the urinary metabolome. Metabolomics. 21(2). 26–26.

Lobo, João, Cármen Jerónimo, Rui Henrique, et al.. (2024). Analysis of MicroRNA-371-373 supports that a subset of spermatocytic tumors demonstrates biologic features similar to those of GCNIS-derived germ cell tumors. Human Pathology. 148. 66–71. 5 indexed citations

Castro, Joana Vieira de, et al.. (2024). Relevance of HOTAIR rs920778 and rs12826786 Genetic Variants in Bladder Cancer Risk and Survival. Cancers. 16(2). 434–434. 2 indexed citations

Mayayo‐Peralta, Isabel, Stefan Preković, Karianne Schuurman, et al.. (2023). Proteomics on malignant pleural effusions reveals ERα loss in metastatic breast cancer associates with SGK1 – NDRG1 deregulation. Molecular Oncology. 18(1). 156–169. 5 indexed citations

Linder, Simon, Tesa Severson, Ekaterina Nevedomskaya, et al.. (2023). Grade Group 1 Prostate Cancers Exhibit Tumor-defining Androgen Receptor–driven Programs. European Urology. 84(5). 455–460. 3 indexed citations

Rocha, Sandra M., Inês M. Gomes, Pedro Costa‐Pinheiro, et al.. (2021). Promoter Demethylation Upregulates STEAP1 Gene Expression in Human Prostate Cancer: In Vitro and In Silico Analysis. Life. 11(11). 1251–1251. 5 indexed citations

Lima, Ana Rita, Márcia Carvalho, Tânia Melo, et al.. (2021). Comprehensive Metabolomics and Lipidomics Profiling of Prostate Cancer Tissue Reveals Metabolic Dysregulations Associated with Disease Development. Journal of Proteome Research. 21(3). 727–739. 20 indexed citations

10.

Adam‐Artigues, Anna, Iris Garrido‐Cano, Ana Lameirinhas, et al.. (2021). Circulating miR-30b-5p levels in plasma as a novel potential biomarker for early detection of breast cancer. ESMO Open. 6(1). 100039–100039. 24 indexed citations

11.

Lobo, João, Vera Constâncio, Vera Miranda‐Gonçalves, et al.. (2021). Promoter methylation of DNA homologous recombination genes is predictive of the responsiveness to PARP inhibitor treatment in testicular germ cell tumors. Molecular Oncology. 15(4). 846–865. 19 indexed citations

12.

Vieira, Filipa Quintela, Vera Miranda‐Gonçalves, Ricardo Ferraz, et al.. (2020). The Impact of [C16Pyr][Amp] on the Aggressiveness in Breast and Prostate Cancer Cell Lines. International Journal of Molecular Sciences. 21(24). 9584–9584. 4 indexed citations

13.

Lima, Ana Rita, Joana Pinto, Daniela Barros‐Silva, et al.. (2020). New findings on urinary prostate cancer metabolome through combined GC–MS and 1H NMR analytical platforms. Metabolomics. 16(6). 29 indexed citations

14.

Garrido‐Cano, Iris, Vera Constâncio, Anna Adam‐Artigues, et al.. (2020). Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer. International Journal of Molecular Sciences. 21(19). 7427–7427. 27 indexed citations

15.

Lima, Ana Rita, Joana Pinto, Daniela Barros‐Silva, et al.. (2019). Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine. British Journal of Cancer. 121(10). 857–868. 82 indexed citations

16.

Luís, Ana, Pedro Costa‐Pinheiro, Luís Antunes, et al.. (2017). SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization. Epigenetics. 12(12). 1057–1064. 14 indexed citations

17.

Carvalho, André Lopes, Rui Henrique, Cármen Jerónimo, et al.. (2011). Detection of Promoter Hypermethylation in Salivary Rinses as a Biomarker for Head and Neck Squamous Cell Carcinoma Surveillance. Clinical Cancer Research. 17(14). 4782–4789. 70 indexed citations

18.

Costa, Vera L., Rui Henrique, Stine A. Danielsen, et al.. (2010). Three Epigenetic Biomarkers, GDF15 , TMEFF2 , and VIM , Accurately Predict Bladder Cancer from DNA-Based Analyses of Urine Samples. Clinical Cancer Research. 16(23). 5842–5851. 139 indexed citations

19.

Hoque, Mohammad Obaidul, Myoung Sook Kim, Kimberly Laskie Ostrow, et al.. (2008). Genome-Wide Promoter Analysis Uncovers Portions of the Cancer Methylome. Cancer Research. 68(8). 2661–2670. 115 indexed citations

20.

Hoque, Mohammad Obaidul, et al.. (2004). Quantitative Detection of Promoter Hypermethylation of Multiple Genes in the Tumor, Urine, and Serum DNA of Patients with Renal Cancer. Cancer Research. 64(15). 5511–5517. 184 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact